• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Obstet Gynecol Sci . COVID-19 and vaccination during pregnancy: a systematic analysis using Korea National Health Insurance claims data

tetano

Editor, Senior Moderator
Obstet Gynecol Sci


. 2022 Aug 2.
doi: 10.5468/ogs.22060. Online ahead of print.
COVID-19 and vaccination during pregnancy: a systematic analysis using Korea National Health Insurance claims data


Ki Hoon Ahn[SUP] 1 [/SUP], Hae-In Kim[SUP] 1 2 3 [/SUP], Kwang-Sig Lee[SUP] 3 [/SUP], Ju Sun Heo[SUP] 4 [/SUP], Ho-Yeon Kim[SUP] 1 [/SUP], Geum-Joon Cho[SUP] 1 [/SUP], Soon-Cheol Hong[SUP] 1 [/SUP], Min-Jeong Oh[SUP] 1 [/SUP], Hae-Joong Kim[SUP] 1 [/SUP]



Affiliations

Abstract

Objective: This study systematically analyzed coronavirus disease 2019 (COVID-19) and vaccination details during pregnancy by using the national health insurance claims data.
Methods: Population-based retrospective cohort data of 12,399,065 women aged 15-49 years were obtained from the Korea National Health Insurance Service claims database between 2019 and 2021. Univariate analysis was performed to compare the obstetric outcomes of pregnant women (ICD-10 O00-O94) and their newborns (ICD-10 P00-P96) with and without COVID-19. Univariate analysis was also performed to compare the age and obstetric outcomes of pregnant women receiving different types of vaccines.
Results: The percentage of pregnant women with COVID-19 during pregnancy was 0.11%. Some obstetric outcomes of pregnant women with COVID-19, including the rates of preterm birth or cesarean delivery, were significantly better than those of pregnant women without COVID-19. The rate of miscarriage was higher in pregnant women with COVID-19 than without COVID-19. However, the outcomes of newborns of women with and without COVID-19 were not significantly different. Regarding vaccination type, obstetric outcomes of pregnant women appeared to be worse with the viral vector vaccine than with the mRNA vaccine.
Conclusion: To the best of our knowledge, this is the first study to systematically analyze COVID-19 and vaccination details during pregnancy using the national health insurance claims data in Korea. The obstetric outcomes in pregnant women with and without COVID-19 and their newborns were similar.

Keywords: COVID-19; Infant, newborn; Pregnancy; Pregnancy outcome; Vaccination.
 
Back
Top Bottom